Page URL:

Film Review: Maximising the Health Benefits of Genetics and Genomics - An Introduction

28 May 2012
Appeared in BioNews 658

Maximising the Health Benefits of Genetics and Genomics: An Introduction

Wellcome Trust, May 2012

Featuring Dr Simon Chaplin and Dr Ultan McDermott

'Maximising the Health Benefits of Genetics and Genomics: An Introduction', Wellcome Trust, May 2012

As a promotional tool to advertise the research funded by the Wellcome Trust, this short film aims both to enthuse and to inform. In both respects it's relatively successful, combining clear and engaging explanations of two projects with smart graphics and shots of impressive-looking equipment. Unfortunately, a slow and rather confusing start may discourage some viewers from reaching the main messages, all of which are in the second half.

The film is composed primarily of interviews with two men: Dr Ultan McDermott of the Wellcome Trust Sanger Institute, who explains the ambitious cancer screening project he runs, and the head of the Wellcome Library, Dr Simon Chaplin, who describes the work of the Trust in archiving material and making it available to the public. Both men are clearly knowledgeable and enthusiastic about the work they do, and although the filming was not always to my taste - the opening shots of Dr McDermott's back as he walks around the corridors of the Sanger Institute seemed a little unnecessary, and his reflection in the glass-fronted cell culture cabinet during his interview was frankly irritating - this did not prevent my enjoyment of the film.

The way the film was structured made it difficult to see initially how the interviews were related so the first few minutes feel a bit disjointed - not necessarily a problem in a 30 minute documentary, but in a five minute film I'm not sure that the casual viewer would persevere.

For those that did, however, the remainder of the short film is a marked improvement. Dr McDermott is excellent, combining his experience as a clinical oncologist and a scientist to bring a human angle to his research into cancer therapeutics. He explains the science in a way that is both succinct and easy to understand, and the potential impact of his research on the cancer field is evident.

Dr Chaplin's inclusion in the film was also an inspired choice: he makes the rather dry subject of archiving and digitising the Trust's historical collection seem relevant and important, and he is well placed to put the Trust's research efforts into genetics and genomics into the context of their other research areas.

As scientists, it is easy for us to forget that the value of our research is greatly enriched by its accessibility not only to the scientific community but to the wider public. The Wellcome Trust is a charitable foundation supporting scientific research in this country and internationally to the tune of £600 million per year, and is committed to making the research it funds freely available. If anything, I felt this could have been given even more weight in the film - after all, had the human genome been sequenced entirely by companies such as Celera Genomics rather than the partially Wellcome Trust-funded Human Genome Project, the patenting of genetic material might have made the kind of research described in the film not possible (1).

Inevitably, a five minute film by the Wellcome Trust about the research it funds is a little one-sided. The film closes with the idea that the cancer genome project will enable doctors to sequence their patients' cancers, check the database for the appropriate mutation and immediately select the best possible chemotherapy. While this promise is unquestionably exciting, there is no mention of the cost of sequencing a genome, which is unlikely to be possible on the NHS in the near future, nor of the difficulty in determining which of the many mutations present in a cancer cell is the driver mutation that causes the disease (2).

Despite this, the film's great success is in communicating the enthusiasm of its two narrators for the research they describe. 'There is something particular about genetics, understanding the make-up of our genetic code, that gives it huge potential to impact on [other areas of research]', says Dr Chaplin in the film. Less than a decade after the sequencing of the first human genome, with huge efforts like the cancer genome project receiving funding from the Wellcome Trust the realisation of that potential seems ever more achievable.

1) Human gene patents defended
BBC News |  27 October 1999
2) Genome sequencing to identify driver pathways in cancer
IEEE Computer magazine |  03/12
10 September 2012 - by Dr Greg Ball 
The Bourne Legacy sees a return of the Bourne franchise, only this time without its eponymous hero, but rather a whole new breed of biologically enhanced undercover CIA agents...
16 July 2012 - by Marco Narajos 
Changing Futures is a website developed by young people as a project led by Nowgen. It contains free online resources, delving into cystic fibrosis (CF) and gene therapy, aimed at teenagers and teachers....
2 April 2012 - by Cait McDonagh 
The world's largest database of medical information has opened online, allowing researchers around the world to access its contents. The UK Biobank holds anonymous information from more than 500,000 British people, making it a 'globally unique resource' according to England's chief medical officer, Dame Sally Davies...
23 January 2012 - by Dr Maria Botcharova 
An experimental genetic technique to prevent serious diseases from passing between mother and child is to receive £5.8 million funding. The Wellcome Trust is contributing £4.4 million to the new Centre for Mitochondrial Research at Newcastle University...
12 September 2011 - by Oliver Timmis 
On 25 July 2011 the Wellcome Trust turned 75, and to celebrate they have commissioned a collection of 15 stories based on some of the most interesting people they have funded...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.